Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

GSK Gsk Plc

-16.80 (-1.00%)
2024年2月22日 - 終了
名称 銘柄コード 市場 種別
Gsk Plc GSK ロンドン Ordinary Share
  前日比 前日比 % 現在値 時刻
-16.80 -1.00% 1,661.00 01:35:19
始値 安値 高値 終値 前日終値
1,660.60 1,655.40 1,665.80 1,661.00 1,677.80
この銘柄の詳細情報 »


日付 時間 ソース タイトル
2024/2/2118:47ALNCNewsGSK reports encouraging results for ViiV's Cabenuva HIV..
2024/2/2116:00UK RNSGSK PLC ViiV LAI superior to orals in adherence-challenged
2024/2/2018:01UK RNSGSK PLC Julie Brown - External Appointment
2024/2/2000:30UK RNSGSK PLC Director/PDMR Shareholding
2024/2/1600:32UK RNSGSK PLC Director/PDMR Shareholding
2024/2/1517:49ALNCNewsGSK completes USD1.4 billion purchase of respiratory firm..
2024/2/1516:00UK RNSGSK PLC GSK completes acquisition of Aiolos Bio
2024/2/1401:45UK RNSGSK PLC Director/PDMR Shareholding - Replacement
2024/2/1400:40UK RNSGSK PLC Director/PDMR Shareholding
2024/2/1400:35UK RNSGSK PLC Director/PDMR Shareholding
2024/2/1400:30UK RNSGSK PLC Director/PDMR Shareholding
2024/2/1317:25ALNCNewsIN THE KNOW: Citi turns positive on GSK after seven years on..
2024/2/1300:39UK RNSGSK PLC Director/PDMR Shareholding
2024/2/1300:38UK RNSGSK PLC Director/PDMR Shareholding
2024/2/1300:26UK RNSGSK PLC Director/PDMR Shareholding
2024/2/1220:36ALNCNewsIN THE KNOW: Goldman Sachs highlights value in magnificent..
2024/2/1217:35ALNCNewsTOP NEWS: GSK's bepirovirsen receives US FDA fast track..
2024/2/1216:00UK RNSGSK PLC US FDA Fast Track designation for bepirovirsen
2024/2/0821:00GLOBEAlector Announces First Patient Dosed in PROGRESS-AD Phase 2..
2024/2/0806:01GLOBE23andMe Reports Third Quarter Fiscal 2024 Financial Results
2024/2/0617:51ALNCNewsTOP NEWS: GSK reports positive news on trio of high profile..
2024/2/0616:10UK RNSGSK PLC FDA accepts Arexvy filing for adults 50-59 at risk
2024/2/0616:05UK RNSGSK PLC Shingrix 18+ at risk China filing review accepted
2024/2/0616:00UK RNSGSK PLC GSK presents positive DREAMM-7 phase III data
2024/2/0200:30UK RNSGSK PLC Director/PDMR Shareholding
2024/2/0200:00UK RNSGSK PLC Total Voting Rights
2024/2/0118:27ALNCNewsTOP NEWS: GSK maintains "vigorous" defence after settling..
2024/2/0116:00UK RNSGSK PLC Statement: Zantac (ranitidine) litigation
2024/1/3120:48ALNCNewsIN THE KNOW: GSK results, pipeline show it's a "serious..
2024/1/3118:13ALNCNewsTOP NEWS: GSK profit up on Arexvy boost in 2023 but total..
2024/1/3116:00UK RNSGSK PLC Final Results
2024/1/2920:52ALNCNewsEARNINGS PREVIEW: Eyes to be on GSK's guidance for Arexvy,..
2024/1/2917:51ALNCNewsGSK seeks expanded use of RSV vaccine in EU, wins approval..
2024/1/2916:05UK RNSGSK PLC EMA accepts Arexvy filing for adults 50-59 at risk
2024/1/2916:00UK RNSGSK PLC European Commission authorises Omjjara in the EU
2024/1/2000:30UKREGGSK PLC Director/PDMR Shareholding
2024/1/1902:00UKREGHaleon PLC Holding(s) in Company
2024/1/1821:49DJNHilleVax Taps Sean McLoughlin as Chief Operating Officer
2024/1/1800:30UKREGGSK PLC Director/PDMR Shareholding
2024/1/1718:38ALNCNewsUPDATE: GSK raises GBP978 million as cuts stake in Haleon to..
2024/1/1718:04DJNCorrection to GSK Article on Tuesday
2024/1/1716:44DJNGSK Sells Haleon Shares Valued Around $1.24 Billion Through..
2024/1/1716:00UKREGGSK PLC GSK completes sale of shares in Haleon plc
2024/1/1702:19DJNGSK to Sell Haleon Shares Worth Around $1.27 Billion
2024/1/1702:04ALNCNewsGSK to sell GBP1 billion worth of Haleon shares as trims..
2024/1/1701:40UKREGGSK PLC GSK announces intention to sell shares in Haleon
2024/1/1700:30UKREGGSK PLC Director/PDMR Shareholding
2024/1/1017:25ALNCNewsGSK says Nucala gets green light in China for asthma..
2024/1/1016:00UKREGGSK PLC Nucala approved in China for use in severe asthma
2024/1/0920:37DJNTrending: GSK Buys Asthma-Specialist Aiolos Bio For Up To..


Delayed Upgrade Clock

ADVFNのサービスをご利用いただくには、 利用規約

Support: +44 (0) 203 8794 460 |